Pharmaceutical Technology
June 02, 2007
Articles
31
6
Pharma companies and CMOs build positions in mAbs.
June 02, 2007
Articles
31
6
Nanotechnology is emerging as a tool for resolving challenges in delivering poorly water soluble and highly potent drugs.
June 02, 2007
Articles
31
6
Pharmaceutical Technology's Annual Manufacturers' Rankings provides perspectives on revenues, product positioning, R&D spending, pharmaceutical manufacturing activity, and capital projects of the major drug companies.
June 02, 2007
Articles
31
6
The racemic compound (R, S)-(±)-ibuprofen is a popular and well understood active pharmaceutical ingredient, but it has several disadvantageous formulation properties such as poor solubility, low melting point, and potential esterification with excipients containing an hydroxyl group. The authors investigate the use of an (R, S)-(±)-ibuprofen salt to evaluate these problems using various analytical methods to determine the polymorphism, crystallinity, and drying scheme.
June 02, 2007
Washington Report
31
6
Product characterization and production challenges are key issues in developing a pathway for biosimilar therapies.
June 02, 2007
Outsourcing
31
6
While some companies float with the tide, others grab market share while business is good.
June 02, 2007
In the Spotlight
31
6
Editors' Picks of Pharmaceutical Science & Technology Innovations
June 02, 2007
From The Editor
31
6
Perhaps Congress can help FDA meet its multiple oversight demands.
June 02, 2007
Packaging Forum
31
6
Exhibitors' products prevent counterfeiting, provide child resistance, protect product quality, and improve packaging-line efficiency.
June 02, 2007
Viewpoint
31
6
Signature authentication technology has evolved to become a stong tool for improving confidence in verification.
June 02, 2007
In the Field
31
6
Boston, MA (May 8)-The global biotechnology industry showed several positive signs in 2006, including increases in overall revenues and financing, although the industry as a whole continues to operate at a loss, according to Ernst & Young's (New York, NY, www.ey.com) annual analysis of the biotechnology industry. Its report, "Beyond Borders 2007," was issued at the Biotechnology Industry Organization's (BIO, www.bio.org) annual conference and exhibition, which was held in Boston May 6–9.